Beta-N-acetylhexosaminidase
From Proteopedia
(Difference between revisions)
| Line 23: | Line 23: | ||
== References == | == References == | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Topic Page]] | ||
Revision as of 08:15, 20 July 2022
| |||||||||||
References
- ↑ Slamova K, Bojarova P, Petraskova L, Kren V. beta-N-acetylhexosaminidase: what's in a name...? Biotechnol Adv. 2010 Nov-Dec;28(6):682-93. doi: 10.1016/j.biotechadv.2010.04.004., Epub 2010 May 9. PMID:20438826 doi:http://dx.doi.org/10.1016/j.biotechadv.2010.04.004
- ↑ Bayleran J, Hechtman P, Kolodny E, Kaback M. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients. Am J Hum Genet. 1987 Oct;41(4):532-48. PMID:2959149
- ↑ Horsch M, Mayer C, Sennhauser U, Rast DM. Beta-N-acetylhexosaminidase: a target for the design of antifungal agents. Pharmacol Ther. 1997 Oct-Dec;76(1-3):187-218. doi: 10.1016/s0163-7258(97)00110-1. PMID:9535180 doi:http://dx.doi.org/10.1016/s0163-7258(97)00110-1
- ↑ Duan Y, Liu T, Zhou Y, Dou T, Yang Q. Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine. J Biol Chem. 2018 Oct 5;293(40):15429-15438. doi: 10.1074/jbc.RA118.004351. Epub , 2018 Aug 22. PMID:30135205 doi:http://dx.doi.org/10.1074/jbc.RA118.004351
